Manchester Eye and Cosmetic Clinic Limited 05676475 false 2023-08-01 2024-07-31 2024-07-31 The principal activity of the company is provision of opthalmic surgery and associated services. Digita Accounts Production Advanced 6.30.9574.0 true false 05676475 2023-08-01 2024-07-31 05676475 2024-07-31 05676475 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2024-07-31 05676475 core:RetainedEarningsAccumulatedLosses 2024-07-31 05676475 core:ShareCapital 2024-07-31 05676475 core:CurrentFinancialInstruments 2024-07-31 05676475 core:CurrentFinancialInstruments core:WithinOneYear 2024-07-31 05676475 core:Non-currentFinancialInstruments 2024-07-31 05676475 core:Non-currentFinancialInstruments core:AfterOneYear 2024-07-31 05676475 core:FurnitureFittings 2024-07-31 05676475 core:OfficeEquipment 2024-07-31 05676475 core:OtherPropertyPlantEquipment 2024-07-31 05676475 bus:SmallEntities 2023-08-01 2024-07-31 05676475 bus:AuditExemptWithAccountantsReport 2023-08-01 2024-07-31 05676475 bus:FilletedAccounts 2023-08-01 2024-07-31 05676475 bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-07-31 05676475 bus:RegisteredOffice 2023-08-01 2024-07-31 05676475 bus:Director1 2023-08-01 2024-07-31 05676475 bus:Director4 2023-08-01 2024-07-31 05676475 bus:Director5 2023-08-01 2024-07-31 05676475 bus:Director6 2023-08-01 2024-07-31 05676475 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2023-08-01 2024-07-31 05676475 bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 05676475 bus:Agent1 2023-08-01 2024-07-31 05676475 core:FurnitureFittings 2023-08-01 2024-07-31 05676475 core:OfficeEquipment 2023-08-01 2024-07-31 05676475 core:OtherPropertyPlantEquipment 2023-08-01 2024-07-31 05676475 core:PlantMachinery 2023-08-01 2024-07-31 05676475 1 2023-08-01 2024-07-31 05676475 countries:England 2023-08-01 2024-07-31 05676475 2023-07-31 05676475 core:FurnitureFittings 2023-07-31 05676475 core:OfficeEquipment 2023-07-31 05676475 core:OtherPropertyPlantEquipment 2023-07-31 05676475 2022-08-01 2023-07-31 05676475 2023-07-31 05676475 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2023-07-31 05676475 core:RetainedEarningsAccumulatedLosses 2023-07-31 05676475 core:ShareCapital 2023-07-31 05676475 core:CurrentFinancialInstruments 2023-07-31 05676475 core:CurrentFinancialInstruments core:WithinOneYear 2023-07-31 05676475 core:Non-currentFinancialInstruments 2023-07-31 05676475 core:Non-currentFinancialInstruments core:AfterOneYear 2023-07-31 05676475 core:FurnitureFittings 2023-07-31 05676475 core:OfficeEquipment 2023-07-31 05676475 core:OtherPropertyPlantEquipment 2023-07-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 05676475

Manchester Eye and Cosmetic Clinic Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 July 2024

 

Manchester Eye and Cosmetic Clinic Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 8

 

Manchester Eye and Cosmetic Clinic Limited

Company Information

Directors

Mr Imran Hakim

Dr Jonathan James Ross

Mr Luke Wren

Mr Sanjay Mantry

Registered office

Unit 317 India Mill Business Centre
Darwen
BB3 1AE

Accountants

Deans Accountants And Business Advisors Ltd 27 North Bridge Street
Hawick
Scottish Borders
TD9 9BD

 

Manchester Eye and Cosmetic Clinic Limited

(Registration number: 05676475)
Balance Sheet as at 31 July 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

124,099

151,347

Current assets

 

Stocks

5

103,291

113,294

Debtors

6

128,180

71,428

Cash at bank and in hand

 

250,669

318,547

 

482,140

503,269

Creditors: Amounts falling due within one year

7

(236,027)

(281,725)

Net current assets

 

246,113

221,544

Total assets less current liabilities

 

370,212

372,891

Creditors: Amounts falling due after more than one year

7

-

(36,048)

Provisions for liabilities

(30,861)

(36,554)

Net assets

 

339,351

300,289

Capital and reserves

 

Called up share capital

8

1,000

1,000

Retained earnings

338,351

299,289

Shareholders' funds

 

339,351

300,289

For the financial year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 28 July 2025 and signed on its behalf by:
 

.........................................
Mr Imran Hakim
Director

.........................................
Dr Jonathan James Ross
Director

.........................................
Mr Sanjay Mantry
Director

 

Manchester Eye and Cosmetic Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Unit 317 India Mill Business Centre
Darwen
BB3 1AE
United Kingdom

These financial statements were authorised for issue by the Board on 28 July 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The accounts are presented in £GBP and are rounded to the nearest £1.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Manchester Eye and Cosmetic Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and Machinery

20% straight line

Fixtures and Fittings

15% straight line

Computer equipmnet

20% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving stocks. Cost in cludes all direct costs and an appropriate proportion of fixed and variable overheads. Work in progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

 

Manchester Eye and Cosmetic Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 24 (2023 - 23).

 

Manchester Eye and Cosmetic Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024

4

Tangible assets

Fixtures and fittings
£

Office equipment
£

Other tangible assets
 £

Total
£

Cost or valuation

At 1 August 2023

8,308

13,948

173,013

195,269

Additions

2,812

-

3,803

6,615

At 31 July 2024

11,120

13,948

176,816

201,884

Depreciation

At 1 August 2023

1,955

5,288

36,679

43,922

Charge for the year

1,298

2,638

29,927

33,863

At 31 July 2024

3,253

7,926

66,606

77,785

Carrying amount

At 31 July 2024

7,867

6,022

110,210

124,099

At 31 July 2023

8,662

6,351

136,334

151,347

5

Stocks

2024
£

2023
£

Other inventories

103,291

113,294

6

Debtors

Current

2024
£

2023
£

Trade debtors

85,336

56,557

Other debtors

42,844

14,871

 

128,180

71,428

7

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2023
£

Due within one year

 

Loans and borrowings

9

-

18,024

Trade creditors

 

55,081

196,213

Taxation and social security

 

14,357

41,813

Other creditors

 

166,589

25,675

 

236,027

281,725

Creditors include bank loans and overdrafts and net obligations under finance lease and hire purchase contracts which are secured of £Nil (2023 - £54,072). This loan was repaid during the year.

 

Manchester Eye and Cosmetic Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024

Creditors: amounts falling due after more than one year

Note

2024
£

2023
£

Due after one year

 

Loans and borrowings

9

-

36,048

8

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary shares of £1 each

1,000

1,000

1,000

1,000

       

9

Loans and borrowings

Non-current loans and borrowings

2024
£

2023
£

Bank borrowings

-

36,048

Current loans and borrowings

2024
£

2023
£

Bank borrowings

-

18,024

10

Related party transactions

Other transactions with directors

Surgical services were provided to the company by individual companies owned by each of the previous directors. The total amounts payable to the individual companies, and the total balances unpaid at the year end were as follows:-

Payable £117,568 unpaid £nil (2023: Payable £231,208 unpaid £30,101). These services ceased on 30th April 2024 following the sale of the business.

 

Manchester Eye and Cosmetic Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024

11

Parent and ultimate parent undertaking

The company's immediate parent is Crescere Holdings Limited, incorporated in England.